Cold
crystallization of amorphous pharmaceuticals is an important
aspect in the search to stabilize amorphous or glassy compounds used
as amorphous pharmaceutical ingredients (APIs). In the present work,
we report results for the isothermal crystallization of the compound
GDC-0276 based on differential scanning calorimetric and rheometric
measurements. The kinetics of isothermal crystallization from the
induction time to the completion of crystallization can be described
by the classic Johnson–Mehl–Avrami (JMA) equation. The
time–temperature-transformation (TTT) diagrams were constructed
for two time pointsthat of induction and that of completion
of crystallization. The results show that the rheological measurement
for GDC-0276 has a better overall sensitivity in detection of the
early stage nucleation and, consequently, detects the onset of crystallization
sooner than does the differential scanning calorimetry. Rheological
measurements were also used to obtain the temperature dependence of
the viscosity of GDC-0276 and the relevant parameters were used in
a modified form of the JMA model to describe the temperature dependence
of the crystal induction and completion times, that is, the TTT diagram
for the material. In the modification, we assumed that the kinetics
followed the viscosity to the 0.75 power as suggested by the recent
work of Huang et al. (Huang, C., et al., J. Chem. Phys.
2018,
149, 054503). The relationship
and the possible impact on crystallization kinetics of the break-down
of the Stokes–Einstein relation in glass-forming liquids are
discussed. From the crystallization kinetics modeling, the solid–liquid
interfacial surface tension σSL was obtained for
GDC-0276 and was compared with that obtained from the melting point
depression measurements of the material confined in nanoporous glasses.
The differences between the values from the two methods are discussed.